122 related articles for article (PubMed ID: 30625326)
1. Double Lock of a Human Neutralizing and Protective Monoclonal Antibody Targeting the Yellow Fever Virus Envelope.
Lu X; Xiao H; Li S; Pang X; Song J; Liu S; Cheng H; Li Y; Wang X; Huang C; Guo T; Ter Meulen J; Daffis S; Yan J; Dai L; Rao Z; Klenk HD; Qi J; Shi Y; Gao GF
Cell Rep; 2019 Jan; 26(2):438-446.e5. PubMed ID: 30625326
[TBL] [Abstract][Full Text] [Related]
2. Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses.
Brandriss MW; Schlesinger JJ; Walsh EE; Briselli M
J Gen Virol; 1986 Feb; 67 ( Pt 2)():229-34. PubMed ID: 3944585
[TBL] [Abstract][Full Text] [Related]
3. Structure-Function of the Yellow Fever Virus Envelope Protein: Analysis of Antibody Epitopes.
Davis EH; Barrett ADT
Viral Immunol; 2020; 33(1):12-21. PubMed ID: 31682201
[TBL] [Abstract][Full Text] [Related]
4. A chimeric yellow fever-Zika virus vaccine candidate fully protects against yellow fever virus infection in mice.
Kum DB; Boudewijns R; Ma J; Mishra N; Schols D; Neyts J; Dallmeier K
Emerg Microbes Infect; 2020; 9(1):520-533. PubMed ID: 32116148
[TBL] [Abstract][Full Text] [Related]
5. Isolation of a Potently Neutralizing and Protective Human Monoclonal Antibody Targeting Yellow Fever Virus.
Doyle MP; Genualdi JR; Bailey AL; Kose N; Gainza C; Rodriguez J; Reeder KM; Nelson CA; Jethva PN; Sutton RE; Bombardi RG; Gross ML; Julander JG; Fremont DH; Diamond MS; Crowe JE
mBio; 2022 Jun; 13(3):e0051222. PubMed ID: 35420472
[TBL] [Abstract][Full Text] [Related]
6. A humanized monoclonal antibody neutralizes yellow fever virus strain 17D-204 in vitro but does not protect a mouse model from disease.
Calvert AE; Dixon KL; Piper J; Bennett SL; Thibodeaux BA; Barrett AD; Roehrig JT; Blair CD
Antiviral Res; 2016 Jul; 131():92-9. PubMed ID: 27126613
[TBL] [Abstract][Full Text] [Related]
7. Neutralizing F(ab')2 fragments of protective monoclonal antibodies to yellow fever virus (YF) envelope protein fail to protect mice against lethal YF encephalitis.
Schlesinger JJ; Chapman S
J Gen Virol; 1995 Jan; 76 ( Pt 1)():217-20. PubMed ID: 7844536
[TBL] [Abstract][Full Text] [Related]
8. A potent neutralizing IgM mAb targeting the N218 epitope on E2 protein protects against Chikungunya virus pathogenesis.
Lam S; Nyo M; Phuektes P; Yew CW; Tan YJ; Chu JJ
MAbs; 2015; 7(6):1178-94. PubMed ID: 26305993
[TBL] [Abstract][Full Text] [Related]
9. A broadly flavivirus cross-neutralizing monoclonal antibody that recognizes a novel epitope within the fusion loop of E protein.
Deng YQ; Dai JX; Ji GH; Jiang T; Wang HJ; Yang HO; Tan WL; Liu R; Yu M; Ge BX; Zhu QY; Qin ED; Guo YJ; Qin CF
PLoS One; 2011 Jan; 6(1):e16059. PubMed ID: 21264311
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection.
Ricciardi MJ; Rust LN; Pedreño-Lopez N; Yusova S; Biswas S; Webb GM; Gonzalez-Nieto L; Voigt TB; Louw JJ; Laurino FD; DiBello JR; Raué HP; Barber-Axthelm AM; Chun K; Uttke S; Raphael LMS; Yrizarry-Medina A; Rosen BC; Agnor R; Gao L; Labriola C; Axthelm M; Smedley J; Julander JG; Bonaldo MC; Walker LM; Messaoudi I; Slifka MK; Burton DR; Kallas EG; Sacha JB; Watkins DI; Burwitz BJ
Sci Transl Med; 2023 Mar; 15(689):eade5795. PubMed ID: 36989376
[TBL] [Abstract][Full Text] [Related]
11. Structural and Functional Characterization of a Cross-Reactive Dengue Virus Neutralizing Antibody that Recognizes a Cryptic Epitope.
Li J; Watterson D; Chang CW; Che XY; Li XQ; Ericsson DJ; Qiu LW; Cai JP; Chen J; Fry SR; Cheung STM; Cooper MA; Young PR; Kobe B
Structure; 2018 Jan; 26(1):51-59.e4. PubMed ID: 29249606
[TBL] [Abstract][Full Text] [Related]
12. Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice.
Gould EA; Buckley A; Barrett AD; Cammack N
J Gen Virol; 1986 Mar; 67 ( Pt 3)():591-5. PubMed ID: 3950582
[TBL] [Abstract][Full Text] [Related]
13. DNA-immunisation with dengue virus E protein domains I/II, but not domain III, enhances Zika, West Nile and Yellow Fever virus infection.
Slon Campos JL; Poggianella M; Marchese S; Mossenta M; Rana J; Arnoldi F; Bestagno M; Burrone OR
PLoS One; 2017; 12(7):e0181734. PubMed ID: 28742857
[TBL] [Abstract][Full Text] [Related]
14. Protection of mice against yellow fever virus encephalitis by immunization with a vaccinia virus recombinant encoding the yellow fever virus non-structural proteins, NS1, NS2a and NS2b.
Putnak JR; Schlesinger JJ
J Gen Virol; 1990 Aug; 71 ( Pt 8)():1697-702. PubMed ID: 2144016
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of the host protein DNAJC14 as a broadly active flavivirus replication modulator.
Yi Z; Sperzel L; Nürnberger C; Bredenbeek PJ; Lubick KJ; Best SM; Stoyanov CT; Law LM; Yuan Z; Rice CM; MacDonald MR
PLoS Pathog; 2011 Jan; 7(1):e1001255. PubMed ID: 21249176
[TBL] [Abstract][Full Text] [Related]
16. Development of antibody-based assays for high throughput discovery and mechanistic study of antiviral agents against yellow fever virus.
Gao Z; Zhang L; Ma J; Jurado A; Hong SH; Guo JT; Rice CM; MacDonald MR; Chang J
Antiviral Res; 2020 Oct; 182():104907. PubMed ID: 32798604
[TBL] [Abstract][Full Text] [Related]
17. Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48.
Schlesinger JJ; Brandriss MW; Walsh EE
J Immunol; 1985 Oct; 135(4):2805-9. PubMed ID: 4031501
[TBL] [Abstract][Full Text] [Related]
18. Yellow fever virus 17D envelope and NS3 proteins are major targets of the antiviral T cell response in mice.
van der Most RG; Harrington LE; Giuggio V; Mahar PL; Ahmed R
Virology; 2002 Apr; 296(1):117-24. PubMed ID: 12036323
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of a purified fragment of 17D yellow fever envelope protein.
Brandriss MW; Schlesinger JJ; Walsh EE
J Infect Dis; 1990 Jun; 161(6):1134-9. PubMed ID: 1693159
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal Antibodies and Flaviviruses: a Possible Option?
Mancini N
mBio; 2022 Jun; 13(3):e0082422. PubMed ID: 35575500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
